These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 11567710)

  • 1. Metformin in non-alcoholic steatohepatitis.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Zoli M; Melchionda N
    Lancet; 2001 Sep; 358(9285):893-4. PubMed ID: 11567710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease.
    Kadayifci A; Merriman RB
    Am J Gastroenterol; 2006 Jun; 101(6):1396; author reply 1396-7. PubMed ID: 16771968
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
    Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
    Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of metformin in nonalcoholic steatohepatitis.
    Mascitelli L; Pezzetta F; Goldstein MR
    Aliment Pharmacol Ther; 2009 Mar; 29(5):602-3; author reply 603-4. PubMed ID: 19183340
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.
    Nadeau KJ; Ehlers LB; Zeitler PS; Love-Osborne K
    Pediatr Diabetes; 2009 Feb; 10(1):5-13. PubMed ID: 18721166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.
    Loomba R; Lutchman G; Kleiner DE; Ricks M; Feld JJ; Borg BB; Modi A; Nagabhyru P; Sumner AE; Liang TJ; Hoofnagle JH
    Aliment Pharmacol Ther; 2009 Jan; 29(2):172-82. PubMed ID: 18945255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver.
    Akcam M; Boyaci A; Pirgon O; Kaya S; Uysal S; Dundar BN
    Int J Vitam Nutr Res; 2011 Nov; 81(6):398-406. PubMed ID: 22673924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin reverses fatty liver disease in obese, leptin-deficient mice.
    Lin HZ; Yang SQ; Chuckaree C; Kuhajda F; Ronnet G; Diehl AM
    Nat Med; 2000 Sep; 6(9):998-1003. PubMed ID: 10973319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
    Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.
    Hasegawa T; Yoneda M; Nakamura K; Makino I; Terano A
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1667-72. PubMed ID: 11564008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study.
    Garinis GA; Fruci B; Mazza A; De Siena M; Abenavoli S; Gulletta E; Ventura V; Greco M; Abenavoli L; Belfiore A
    Int J Obes (Lond); 2010 Aug; 34(8):1255-64. PubMed ID: 20179669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.
    Schwimmer JB; Middleton MS; Deutsch R; Lavine JE
    Aliment Pharmacol Ther; 2005 Apr; 21(7):871-9. PubMed ID: 15801922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis.
    Rakoski MO; Singal AG; Rogers MA; Conjeevaram H
    Aliment Pharmacol Ther; 2010 Nov; 32(10):1211-21. PubMed ID: 20955440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological issues.
    Ratziu V; Caldwell S; Neuschwander-Tetri BA
    Hepatology; 2010 Dec; 52(6):2206-15. PubMed ID: 21105109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial.
    Nair S; Diehl AM; Wiseman M; Farr GH; Perrillo RP
    Aliment Pharmacol Ther; 2004 Jul; 20(1):23-8. PubMed ID: 15225167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.
    Haukeland JW; Konopski Z; Eggesbø HB; von Volkmann HL; Raschpichler G; Bjøro K; Haaland T; Løberg EM; Birkeland K
    Scand J Gastroenterol; 2009; 44(7):853-60. PubMed ID: 19811343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
    Huang Y; Fu JF; Shi HB; Liu LR
    Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.